Login to Your Account



Pharma: Other News To Note


Tuesday, September 24, 2013
• Teva Pharmaceutical Industries Ltd., of Petach Tikva, Israel, said that the U.S. District Court for the District of New Jersey gave it a favorable ruling in a patent infringement lawsuit against Mylan related to Azilect (rasagiline tablets) for Parkinson’s disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription